Scientists are excitedly investigating retatrutide, a innovative medication from Eli Lilly, as a possible step in body reduction . Distinct from many earlier approaches, retatrutide is a dual -action compound targeting both GLP-1 and GIP, hormones that impact hunger and blood sugar control . Ear… Read More